Glycemic Index of Sweet Corn
Determination of the Glycemic Index of Differently Processed Sweet Corn
2 other identifiers
interventional
45
1 country
2
Brief Summary
Processing sweet corn may impact digestibility and, therefore, glycemic response following consumption. The primary aim of this study is to assess the glycemic index of various sweet corn products and varieties. An exploratory aim is to assess hunger/satiety scores following sweet corn intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2025
CompletedFirst Posted
Study publicly available on registry
February 26, 2025
CompletedStudy Start
First participant enrolled
March 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedMarch 31, 2026
August 1, 2025
3 months
February 21, 2025
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
iAUC
Incremental area under the glycemic response curve (iAUC)
From enrollment to the end of 5 weeks.
Secondary Outcomes (1)
Hunger and Satiety Score
From enrollment to the end of 5 weeks.
Study Arms (2)
Glucose Tolerance Drink
ACTIVE COMPARATOR50 g glucose beverage
Sweet corn
EXPERIMENTALSweet corn providing 50 g of available carbohydrate
Interventions
Eligibility Criteria
You may qualify if:
- Able to provide written consent in English
- Willing to consume 50 g of glucose in less than 15 minutes (2 mornings)
- Willing to consume around 250 to 350 g of sweet corn in 10 to 15 minutes (3 mornings)
- Willing to provide 7 capillary blood samples by fingerstick (by fine lancet) during each 2-hour session
You may not qualify if:
- Metabolic disease or condition affecting blood glucose, such as diabetes type 1 and 2, metabolic syndrome, or polycystic ovary syndrome
- Baseline fasting blood glucose \> 100 mg/dL
- Currently pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Food Science and Human Nutrition Building
Gainesville, Florida, 32611, United States
University of Florida
Gainesville, Florida, 32611, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Statistician
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2025
First Posted
February 26, 2025
Study Start
March 5, 2025
Primary Completion
June 17, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
March 31, 2026
Record last verified: 2025-08